Surgalign Holdings, Inc. provided revenue guidance for the year 2021. For the year, the company anticipates full year revenue to grow in the range of 7% to 10% compared to the prior year global spine revenue of approximately $102 million. The company guidance assumes that global procedure volumes return to normal levels during the second quarter of 2021.